Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$13.35 USD
+0.19 (1.44%)
Updated May 31, 2024 04:00 PM ET
After-Market: $13.35 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.35 USD
+0.19 (1.44%)
Updated May 31, 2024 04:00 PM ET
After-Market: $13.35 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
Zacks News
Top Ranked Growth Stocks to Buy for August 8th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 8th:
Tyson Foods (TSN) Beats on Q3 Earnings & Sales, Stock Up
by Zacks Equity Research
Tyson Foods' (TSN) shares were up during pre-market trading hours on the back of better-than-expected results.
Conagra (CAG) Braves Headwinds with Robust Growth Drivers
by Zacks Equity Research
Conagra Brands (CAG) is poised to grow on greater innovation and sound restructuring moves. But headwinds like stiff industry rivalry and unfavorable foreign currency translation might limit growth.
TreeHouse (THS) Tops Q2 Earnings, Cuts View on Soft Volumes
by Zacks Equity Research
TreeHouse Foods' (THS) earnings and sales for the second quarter were mainly impacted by divestiture, unfavorable volume/mix, foreign currency fluctuations and pricing.
Avon (AVP) Falls on Q2 Loss & Sales Lag, Cuts FY17 View
by Zacks Equity Research
Avon Products Inc. (AVP) reported dismal second-quarter 2017 results, wherein both adjusted loss per share and revenues lagged estimates.
Nu Skin (NUS) Tops Q2 Earnings and Sales, Currency a Woe
by Zacks Equity Research
Nu Skin's (NUS) top line declined primarily due to negative impacts of currency fluctuations and dismal regional revenues.
Molson Coors (TAP) Q2 Earnings Lag, Currency Plays Spoilsport
by Zacks Equity Research
Molson Coors (TAP) sales gained from strong growth in Europe and International regions owing to the addition of Miller global brands business. However, currency dented company's earnings in the second quarter.
Stericycle (SRCL) to Report Q2 Earnings: What Lies Ahead?
by Zacks Equity Research
Focus on increasing operational efficiency and continuous investments in data analytic capabilities to improve its performance are likely to drive Stericycle's (SRCL) Q2 earnings.
Diageo (DEO) FY17 Earnings: Sales and Productivity Go Up
by Zacks Equity Research
Diageo's (DEO) organic net sales grew across all its segments owing to improved operating efficiency and productivity initiatives.
Is Church & Dwight (CHD) Poised for a Beat in Q2 Earnings?
by Zacks Equity Research
Church & Dwight (CHD) is likely to offset headwinds on the back of a stable portfolio of value and premium products, aggressive acquisitions and productivity programs and tight management of overhead expenses in Q2.
What's in Store for Treehouse Foods (THS) in Q2 Earnings?
by Zacks Equity Research
Treehouse Foods (THS) has been battling rising cost of operations and changing consumer preferences, which are expected to hurt second-quarter results.
Pilgrim's Pride (PPC) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 results will likely gain traction from the Newport buyout and solid demand. However, persistent headwinds in the industry remain key concerns.
Is a Beat in Store for Nu Skin (NUS) this Earnings Season?
by Zacks Equity Research
Nu Skin (NUS) has been exhibiting robust growth in its ageLOC Me and ageLOC Youth products, which has encouraged management to continue with its innovation and product launches.
Is Nu Skin Enterprises (NUS) a Great Stock for Value Investors?
by Zacks Equity Research
Is Nu Skin Enterprises a great pick from the value investor's perspective right now? Read on to know more.
Avon (AVP) Delivers Q1 Loss, Transformation Plan Looks Good
by Zacks Equity Research
Avon Products Inc. (AVP) posted adjusted loss from continuing operations of 7 cents per share for first-quarter 2017, lagging the Zacks Consensus Estimate of break-even.
Are Options Traders Betting on a Big Move in Nu Skin Enterprises (NUS) Stock?
by Zacks Equity Research
Nu Skin Enterprises (NUS) warrants investors' attention based on moves in the options market lately.
Estee Lauder (EL) Stock Up on Q3 Earnings, Sales Beat
by Zacks Equity Research
Estee Lauder Companies Inc. (EL) continues to impress investors with better-than-expected earnings for the eleventh consecutive quarter, when the company reported third-quarter fiscal 2017 results.
Can Nu Skin (NUS) Spring a Surprise This Earnings Season?
by Zacks Equity Research
Nu Skin (NUS) is all set to report first-quarter 2017 results on May 3, after the closing bell.
Nu Skin Enterprises (NUS) Appoints New Managerial Positions
by Zacks Equity Research
Nu Skin Enterprises Inc. (NUS) has recently appointed Mark H. Lawrence as its new chief financial officer (CFO), who will take position from Mar 27. Lawrence will succeed Ritch Wood, who will now be the company's chief executive officer (CEO), as announced in Dec 2016.
Consumer Staples Stock Earnings on Feb 16: AVP, NUS & ELF
by Zacks Equity Research
Let's take a look at what's in store for the following consumer staples stocks which are likely to release their fourth-quarter 2016 results on Feb 16.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards? (revised)
by Zacks Equity Research
Despite the positives, the company faces several regulatory issues.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards?
by Zacks Equity Research
Nu-Skin Enterprises, Inc. (NUS) is set to report fourth-quarter 2016 results on Feb 13, after the market closes. The question lingering in investors' minds is, whether the company will be able to deliver a positive earnings surprise in the to-be-reported quarter.
Can Nu Skin Be a Solid Choice for Value Investors?
by Zacks Equity Research
Let's see if company Nu Skin Enterprises Inc. (NUS) stock is a good choice for value-oriented investors right now from multiple angles
Nu Skin (NUS) Provides Weak 2016 Sales View; CEO to Exit
by Zacks Equity Research
Nu Skin Enterprises Inc. (NUS) recently updated its financial guidance for 2016, wherein it expects sluggish sales growth and also announced the exit of its Chief Executive Officer ("CEO"). Shares of Nu Skin declined 7.2% yesterday after the news. The company also provided an initial guidance for 2017.
New Strong Buy Stocks for September 26th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday